skip to main content
Idioma:
Resultados 1 2 next page
Mostrar Somente
Refinado por: autor: Hochman, J remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Patient & physician preferences for therapy of an occluded infarct-related artery late after myocardial infarction. Observations from the occluded artery trial-oat registry
Patient & physician preferences for therapy of an occluded infarct-related artery late after myocardial infarction. Observations from the occluded artery trial-oat registry
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Patient & physician preferences for therapy of an occluded infarct-related artery late after myocardial infarction. Observations from the occluded artery trial-oat registry

Antônio Carvalho Rosley Fernandes; Paulo Caramori; Maurício Machado; Gilmar Reis; José Antônio Marin-Neto; Moysés Lima; Sandra Forman; Gervásio Lamas; Judith Hochman; Congresso da Sociedade Latino-Americana de Cardiologia Intervencionista (SOLACI (9. 2003 São Paulo); Congresso da Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista (25. 2003 São Paulo)

Arquivos Brasileiros de Cardiologia São Paulo v. 81, supl.1 , p. 22, res. 070, 2003

São Paulo 2003

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1350142 ) e outros locais(Acessar)

2
Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial
Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial

Pierre Theroux Paul W Armstrong; Lina M Gonzales; Kenneth W Mahaffey; Judith S Hochman; Scott Rollins; Kevin J Malloy; Thomas Parish; José Carlos Nicolau; Joel Lavoie; Christopher B Granger; Annual Scientific Session American College of Cardiology (53. 2004 New Orleans, EUA)

Journal American College of Cardiology New York v.43, suppl. A, p. 287A, res. 833-5, 2004

New York 2004

Localização: FM - Fac. Medicina    (BCSEP 2004 65 ) e outros locais(Acessar)

3
Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction results from the cardinal trial
Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction results from the cardinal trial
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction results from the cardinal trial

Manesh R. Patel Kenneth W Mahaffey; Paul W Amstrong; W. Douglas Weaver; Tasissa Gudaye; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Thomas H Parish; Scott Rollins; Pierre Theroux; Wiltold Ruzyllo; José Carlos Nicolau; Cristopher B Granger; Annual Scientific Session American College of Cardiology (53. 2004 New Orleans, EUA)

Journal American College of Cardiology New York v.43, suppl. A, p. 291A, res. 1118-102, 2004

New York 2004

Localização: FM - Fac. Medicina    (BCSEP 2004 65 ) e outros locais(Acessar)

4
Infarct size, viability, and correlates in patients presenting with a persistent total occlusion of the infarct-related artery 3-28 days post myocardial infarction an occluded artery trial (OAT) substudy
Infarct size, viability, and correlates in patients presenting with a persistent total occlusion of the infarct-related artery 3-28 days post myocardial infarction an occluded artery trial (OAT) substudy
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Infarct size, viability, and correlates in patients presenting with a persistent total occlusion of the infarct-related artery 3-28 days post myocardial infarction an occluded artery trial (OAT) substudy

Camille A. Pearle James E Udelson; Mariusz Kruk; Harmony R Reynolds; Witold Ruzyllo; Zygmund Sadowski; Anna Teresinska; Barbosz Bychowiec; Thomas Höchtl; José Antonio Marin Neto; Eric A Cohen; Benita Busz Papiez; Paulo Caramori; Gervasio A Adilbrecht; Carey Kimmelstiel; Christopher E Buller; Sandra Forman; Gervasio A Lamas; Judith S Hochman; Annual Scientific Session (56. 2007 New York)

Journal of American College Cardiology New York v. 49, n. 9, on-line, 2007

New York 2007

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1647082 ) e outros locais(Acessar)

5
Predictors of outcome and the lack of effect of PCI across the risk strata in patients with persistent total occlusion after myocardial infarction results from the occluded artery trial
Predictors of outcome and the lack of effect of PCI across the risk strata in patients with persistent total occlusion after myocardial infarction results from the occluded artery trial
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Predictors of outcome and the lack of effect of PCI across the risk strata in patients with persistent total occlusion after myocardial infarction results from the occluded artery trial

Mariusz Kruk Jacek Kadziela; Zygmunt P Sadowski; Bruce A Barton; Daniel B Mark; Sandra A Forman; Harmony R Reynolds; Aldo P Maggioni; Jonathan Leor; John G Webb; Michael Kapeliovich; José Antônio Marin-Neto; Harvey D White; Gervasio A Lamas; Judith S Hochman; Scientific Sessions of The American Heart Association(AHA) (2007 Orlando)

Abstracts Orlando, 2007

Orlando 2007

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1642702 ) e outros locais(Acessar)

6
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial

Christopher B. Granger Kenneth W Mahaffey; Douglas Weaver; Pierre Theroux; Judith Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todado; Witold Ruzyllo; Paul W Armstrong; José C Nicolau

Circulation, Baltimore v. 18, p. 1184-1190

Baltimore 2003

Item não circula. Consulte sua biblioteca.(Acessar)

7
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial

Christopher B. Granger Kenneth W Mahaffey; Douglas Weaver; Pierre Theroux; Judith Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todado; Witold Ruzyllo; Paul W Armstrong; José C Nicolau

Circulation, Baltimore v. 18, p. 1184-1190

Baltimore 2003

Item não circula. Consulte sua biblioteca.(Acessar)

8
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)

Manesh R. Patel Kenneth W Mahaffey; Paul W Armstrong; W. Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rolins; Pierre Therou; Witold Ruzyllo; José Carlos Nicolau; Christopher B Granger

American Journal of Cardiology Orlando v. 95, n. 5, p. 614-618, March, 2005

Orlando 2005

Localização: FM - Fac. Medicina    (FM BCBIB )(Acessar)

9
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)

Manesh R. Patel Kenneth W Mahaffey; Paul W Armstrong; W. Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rolins; Pierre Therou; Witold Ruzyllo; José Carlos Nicolau; Christopher B Granger

American Journal of Cardiology Orlando v. 95, n. 5, p. 614-618, March, 2005

Orlando 2005

Localização: FM - Fac. Medicina    (FM BCBIB )(Acessar)

10
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial

Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong

Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003

Philadelphia 2003

Item não circula. Consulte sua biblioteca.(Acessar)

Resultados 1 2 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Mostrar Somente

  1. Disponível na Biblioteca (9)

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Hochman, J
  2. Ruzyllo, W
  3. Granger, C
  4. Nicolau, J
  5. Mahaffey, K

Neste Assunto:

  1. Infarto Do Miocárdio
  2. Inflamação
  3. Prognóstico
  4. Contagem De Leucócitos
  5. Infarto Do Miocárdio (Patologia)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.